These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10653202)

  • 1. Comparison of the frequency of behavioral disinhibition on alprazolam, clonazepam, or no benzodiazepine in hospitalized psychiatric patients.
    Rothschild AJ; Shindul-Rothschild JA; Viguera A; Murray M; Brewster S
    J Clin Psychopharmacol; 2000 Feb; 20(1):7-11. PubMed ID: 10653202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Withdrawal and detoxification from benzodiazepine dependence: a potential role for clonazepam.
    Albeck JH
    J Clin Psychiatry; 1987 Oct; 48 Suppl():43-9. PubMed ID: 2889723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Addiction to benzodiazepines - analysis of patients of Independent Public Hospital for Mental Diseases Patients in Międzyrzecz].
    Szymański M; Korzeniowska K; Jabłecka A
    Przegl Lek; 2016; 73(10):737-40. PubMed ID: 29689153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder.
    Otto MW; Pollack MH; Sachs GS; Reiter SR; Meltzer-Brody S; Rosenbaum JF
    Am J Psychiatry; 1993 Oct; 150(10):1485-90. PubMed ID: 8379551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
    Tesar GE; Rosenbaum JF; Pollack MH; Otto MW; Sachs GS; Herman JB; Cohen LS; Spier SA
    J Clin Psychiatry; 1991 Feb; 52(2):69-76. PubMed ID: 1993639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case Report of Clonazepam Dependence: Utilization of Therapeutic Drug Monitoring During Withdrawal Period.
    Kacirova I; Grundmann M; Silhan P; Brozmanova H
    Medicine (Baltimore); 2016 Mar; 95(9):e2881. PubMed ID: 26945373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, pharmacodynamics, and treatment issues of benzodiazepines: alprazolam, adinazolam, and clonazepam.
    DeVane CL; Ware MR; Lydiard RB
    Psychopharmacol Bull; 1991; 27(4):463-73. PubMed ID: 1687613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catatonia after benzodiazepine withdrawal.
    Rosebush PI; Mazurek MF
    J Clin Psychopharmacol; 1996 Aug; 16(4):315-9. PubMed ID: 8835707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzodiazepine-associated atrioventricular block.
    Arroyo Plasencia AM; Ballentine LM; Mowry JB; Kao LW
    Am J Ther; 2012 Jan; 19(1):e48-52. PubMed ID: 20535011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of alprazolam and clonazepam dose to steady-state concentration in plasma.
    Labbate LA; Pollack MH; Otto MW; Tesar GM; Rosenbaum JF
    J Clin Psychopharmacol; 1994 Aug; 14(4):274-6. PubMed ID: 7962684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonazepam-Related Paradoxical Behavioral Disinhibition: An Uncommon But Grave Adverse Effect.
    Gandotra K; Chen P; Konicki PE; Strohl KP
    J Clin Psychopharmacol; 2019; 39(3):281-282. PubMed ID: 30939591
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of panic disorder and agoraphobia with clonazepam.
    Spier SA; Tesar GE; Rosenbaum JF; Woods SW
    J Clin Psychiatry; 1986 May; 47(5):238-42. PubMed ID: 3700341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New concepts in benzodiazepine therapy: rebound anxiety and new indications for the more potent benzodiazepines.
    Chouinard G; Labonte A; Fontaine R; Annable L
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):669-73. PubMed ID: 6141609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawal from alprazolam dependency using clonazepam: clinical observations.
    Patterson JF
    J Clin Psychiatry; 1990 May; 51 Suppl():47-9; discussion 50-3. PubMed ID: 2335501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preference for alprazolam as opposed to diazepam in benzodiazepine-dependent psychiatric inpatients.
    Apelt S; Schmauss C; Emrich HM
    Pharmacopsychiatry; 1990 Mar; 23(2):70-5. PubMed ID: 1971118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines.
    Herman JB; Brotman AW; Rosenbaum JF
    J Clin Psychiatry; 1987 Oct; 48 Suppl():22-8. PubMed ID: 2889722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial.
    Tesar GE; Rosenbaum JF; Pollack MH; Herman JB; Sachs GS; Mahoney EM; Cohen LS; McNamara M; Goldstein S
    J Clin Psychiatry; 1987 Oct; 48 Suppl():16-21. PubMed ID: 3312179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based case-control teratologic study of nitrazepam, medazepam, tofisopam, alprazolum and clonazepam treatment during pregnancy.
    Eros E; Czeizel AE; Rockenbauer M; Sorensen HT; Olsen J
    Eur J Obstet Gynecol Reprod Biol; 2002 Mar; 101(2):147-54. PubMed ID: 11858890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.